10 Medicine Groups You Will Often Meet on Placement

Drug classes are useful because they help you recognise patterns. Once you know that a medicine is an opioid, beta blocker or anticoagulant, you already have clues about why it may have been prescribed, what effects you might expect and what safety checks may matter.

But a drug class is only the starting point. It does not tell you the exact dose, route, contraindications, interactions or monitoring needed for the individual medicine in front of you. Two medicines from the same broad group can behave very differently.

On placement, the aim is not to memorise the British National Formulary. It is to build a safe way of thinking: identify the medicine, understand why this patient is receiving it, check what matters before administration, then monitor what happens afterwards.

What does a drug class actually tell you?

A drug class groups medicines that share a feature, such as their mechanism, therapeutic effect or clinical use. That can help you predict patterns, but it should never replace checking the actual medicine.

For any medicine, you still need to consider:

• the generic name and exact formulation
• the prescribed dose, route, frequency and timing
• the indication for this patient
• allergies and previous adverse reactions
• current observations and clinical condition
• relevant renal or liver function
• electrolytes, blood counts or other required blood results
• interactions and duplicate medicines
• any medicine specific monitoring
• local policy and your level of competence

NICE medicines optimisation guidance emphasises reviewing why medicines are being used, whether they remain safe and effective, and what monitoring is required. That is a much more useful placement mindset than learning a list of names.

UK note: NICE guidance is used within NHS practice in England, while Scotland has its own national medicines guidance and prescribing systems. The same core principles of person centred review, appropriate indication, effectiveness, safety and monitoring are also reflected in current Scottish Government polypharmacy guidance. Students should therefore follow the national and local guidance used in their placement area.

A safer way to approach any medicine

Before you worry about memorising every side effect, use the same six questions every time:

1. Name and class: What is the generic name and what group does it belong to?
2. Why this patient? What is the indication in this person's current clinical picture?
3. What needs checking first? Think prescription, allergy status, observations, blood results, timing, route and interactions.
4. How is it given safely? Follow the prescription, local policy, product information and the supervision required in your placement area.
5. What response should I look for? Pain relief, improved blood pressure, better breathing or another intended effect.
6. What would make me pause? An unclear prescription, unexpected observations, abnormal blood results, a possible interaction, a new adverse effect or anything that does not fit.

The ten medicine groups you will meet often

These are broad groups rather than a complete pharmacology syllabus. You will see different medicines depending on your placement, but these ten give you a useful foundation for ward based practice.

1. Analgesics

Analgesics reduce pain, but the group contains medicines with very different mechanisms and risks.

Common examples

• Paracetamol
• Non steroidal anti inflammatory drugs, such as ibuprofen or naproxen
• Opioids, such as morphine, oxycodone or codeine

What matters before administration?

Start with the patient's pain assessment and the prescription. With paracetamol, check total exposure because it can appear in combination products. With non steroidal anti inflammatory drugs, renal function, gastrointestinal risk, bleeding risk and other medicines may be relevant. With opioids, respiratory status, sedation, previous doses, route and concurrent sedating medicines matter.

What should you monitor afterwards?

Do not stop at signing the chart. Reassess whether the pain has improved and look for adverse effects. Opioids can cause sedation, nausea, constipation and respiratory depression. The exact observations and escalation thresholds should follow local policy and the patient's clinical plan.

Placement trap: treating all pain relief as interchangeable. A patient who can safely receive paracetamol may not be an appropriate candidate for a non steroidal anti inflammatory drug or opioid.

2. Antimicrobials

Antimicrobials include antibiotics, antivirals and antifungals. Even within antibiotics, different groups have different spectra, routes, monitoring and adverse effects.

Before administration

• Check the allergy status and what reaction the patient previously experienced.
• Confirm the indication where this is known.
• Check whether cultures or other microbiology samples were requested before the first dose.
• Check timing carefully, particularly where treatment is urgent or doses need to be spaced accurately.
• Review renal or hepatic function when relevant to the prescribed medicine.

If a patient develops features suggesting an allergic reaction or acute deterioration during or after an antimicrobial, stop what you are doing and escalate according to the clinical situation and local policy.

Placement trap: thinking an antibiotic is safe simply because the patient has received it before. Allergy status, renal function, current infection, dose and route still need checking.

3. Anticoagulants and antiplatelets

These are grouped together here because both are commonly encountered when thinking about thrombosis and bleeding, but they are not the same pharmacological group.

Anticoagulants act on the coagulation system. Examples include low molecular weight heparins, warfarin and direct oral anticoagulants such as apixaban or rivaroxaban. Antiplatelets reduce platelet activation or aggregation. Examples include aspirin and clopidogrel.

Before administration

Check the indication, dose, timing, signs of active bleeding and any relevant procedure plan. Renal function is important for some anticoagulants. Warfarin management involves the international normalised ratio, commonly shortened to INR, whereas direct oral anticoagulants are not routinely dose adjusted using INR.

Low molecular weight heparin may be prescribed at different doses for prevention and treatment. Never assume the dose is correct simply because the medicine name is familiar.

What should make you concerned?

New bleeding, unexplained bruising, haemodynamic change, severe headache, new neurological symptoms or a significant fall in haemoglobin may require urgent review depending on the context. Omitted anticoagulant doses can also matter, so do not quietly leave an unclear dose unsigned or assume it can wait until later.

Placement trap: describing aspirin and apixaban as though they do the same thing because both can increase bleeding risk.

4. Antihypertensives

Antihypertensives lower blood pressure through different mechanisms. Common groups include angiotensin converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers and beta blockers.

Checks depend on the medicine

Blood pressure is an obvious consideration, but it is not the only one. Pulse may be particularly relevant for some beta blockers. Renal function and potassium are important considerations with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Symptoms such as dizziness, syncope or evidence of acute illness also matter.

There is no single blood pressure or pulse value that tells a student to independently withhold every antihypertensive. Use the prescription, local parameters and patient specific plan. If the observations are outside the expected range or the patient has changed clinically, pause and ask the registered nurse or prescriber.

Placement trap: memorising a universal hold number instead of understanding the medicine and the patient's plan.

5. Diuretics

Diuretics increase renal excretion of sodium and water to different degrees. Common groups include loop diuretics, thiazide like diuretics and potassium sparing diuretics.

What should you connect together?

• blood pressure and symptoms
• fluid balance and urine output
• weight trend where clinically relevant
• renal function
• sodium and potassium
• the reason the diuretic has been prescribed

Different diuretics can affect electrolytes differently. A potassium sparing medicine should not be treated as though it has the same electrolyte effects as a loop diuretic.

Placement trap: assuming ankle oedema automatically means the patient has too much circulating volume. Fluid can be distributed abnormally, and clinical assessment matters.

6. Diabetes medicines

This group includes insulin, metformin, sulfonylureas, sodium glucose cotransporter 2 inhibitors, often shortened to SGLT2 inhibitors, GLP 1 receptor agonists and other medicines. Their risks are very different.

Insulin

Insulin is a high risk medicine because errors in product, strength, dose or timing can cause serious harm. Check the exact insulin product, prescribed dose, blood glucose, timing in relation to food where relevant, device and local administration process. High strength and combination insulin products make it especially important not to assume that all insulins are interchangeable.

Sulfonylureas

Medicines such as gliclazide can cause hypoglycaemia, so connect the medicine with blood glucose, oral intake and the patient's current condition.

Metformin

Renal function and acute illness can matter. If the patient's condition has changed substantially, do not independently invent a sick day plan. Check the prescription and local guidance and escalate for review.

SGLT2 inhibitors

SGLT2 inhibitors have an important association with diabetic ketoacidosis, which can occasionally occur without very high blood glucose. MHRA safety advice recommends treatment interruption during hospitalisation for major surgery or acute serious illness, with blood ketone monitoring during the interruption. As a student, your role is to recognise the issue, check the documented plan and escalate if the medicine appears inconsistent with the patient's clinical situation.

Placement trap: seeing a normal or moderately raised glucose and assuming diabetic ketoacidosis is impossible in a patient taking an SGLT2 inhibitor.

Three groups that deserve an extra pause

Opioids, anticoagulants and insulin are good examples of medicines where the final safety check is not just the name on the prescription. Their effect can be strongly influenced by the patient's current observations, blood results, timing and clinical state.

7. Respiratory medicines

Respiratory medicines include short acting bronchodilators, long acting bronchodilators, inhaled corticosteroids and combination inhalers. The device matters as much as the active medicine because poor technique can mean very little drug reaches the lungs.

Useful checks

• What inhaler or nebuliser has actually been prescribed?
• Can the patient use the device correctly?
• Is a spacer required or prescribed?
• What symptoms and respiratory observations are being monitored?
• Has the patient responded to treatment?

Beta agonists can cause effects such as tremor and tachycardia. Inhaled corticosteroids can contribute to oral candidiasis, so correct technique and mouth care advice may be relevant according to the product and local guidance.

Placement trap: assuming a nebuliser is automatically stronger or more appropriate than an inhaler. The delivery method and clinical indication matter.

8. Corticosteroids

Corticosteroids may be prescribed orally, intravenously, by inhalation, topically or by injection. The route, dose and duration change the risk profile.

Systemic corticosteroids can affect blood glucose, mood, infection risk, gastrointestinal symptoms and adrenal function. Longer courses or repeated treatment can make adrenal suppression clinically important.

Do not tell a patient to stop long term systemic corticosteroids abruptly. If the treatment plan appears unclear, ask the registered nurse, pharmacist or prescriber. Some patients will also have steroid emergency information or a steroid card according to their treatment and risk.

Placement trap: thinking “steroid” is a single medicine with a single set of side effects regardless of route or duration.

9. Psychotropic medicines

Psychotropic medicines include antidepressants, antipsychotics, mood stabilisers and medicines used for anxiety or sleep. These groups have different mechanisms, indications and monitoring requirements.

What might you need to notice?

• changes in mental state
• sedation or reduced alertness
• postural symptoms or blood pressure changes
• movement abnormalities
• electrocardiogram monitoring for selected medicines
• blood results or drug levels where specifically required
• new adverse effects or changes in behaviour

Some medicines have particularly narrow safety margins or medicine specific monitoring requirements. Lithium, for example, is not managed like a routine sedative and requires its own monitoring plan.

Placement trap: treating drowsiness as an expected effect that does not need reassessment. Sedation can still be clinically significant.

10. Gastrointestinal medicines

Common gastrointestinal medicines include proton pump inhibitors, antiemetics and laxatives. They are common enough to become familiar, but familiar does not mean risk free.

Proton pump inhibitors

Check why the medicine is being used and whether the indication still makes sense, particularly with long term treatment.

Antiemetics

Different antiemetics have different adverse effect profiles. Selected medicines can affect cardiac repolarisation or cause movement related adverse effects, so the exact drug and patient risk factors matter.

Laxatives

The type of laxative should fit the problem being treated. Bowel pattern, hydration, abdominal symptoms and electrolyte status may matter depending on the medicine and clinical situation.

Placement trap: giving a familiar “routine” gastrointestinal medicine without checking why it is prescribed or whether the patient's condition has changed.

How to use the BNF on placement

The British National Formulary is much more useful when you know what you are looking for. When you meet an unfamiliar medicine, search the generic name and work through the information that answers your clinical question.

Useful sections include:

• Indications and dose: why is it used and does the prescribed route and schedule make sense?
• Contraindications and cautions: is there something about this patient that changes the risk?
• Interactions: could another medicine alter its effect or increase harm?
• Side effects: what important adverse effects should you recognise?
• Renal and hepatic impairment: does organ function affect use or dosing?
• Monitoring requirements: are observations, blood tests, drug levels or other checks required?

The BNF supports safe decision making, but it does not replace the current prescription, local policy, medicine specific protocol or assessment of the patient in front of you.

Common medicine mistakes students should learn to spot

• Confusing a brand name with the generic medicine.
• Assuming every medicine in one class has the same dose or monitoring.
• Missing duplicate active ingredients.
• Seeing “allergy” without checking what reaction occurred.
• Not noticing a change in formulation, strength or device.
• Ignoring renal function or electrolytes when they are relevant.
• Giving a medicine because it is due without checking whether the patient's condition has changed.
• Leaving an omitted dose unexplained.
• Signing administration without assessing the expected response afterwards.
• Continuing when the prescription is unclear instead of asking.

Three placement examples

Example 1: opioid and increasing drowsiness

A patient is due morphine but is noticeably more drowsy than earlier and their respiratory rate has fallen from their usual pattern. The safe response is not to administer automatically because the medicine is due. Reassess, check the observations and prescription, and ask the registered nurse for review before proceeding.

Example 2: antihypertensive and a changed clinical picture

A patient is due an angiotensin converting enzyme inhibitor, but their blood pressure is lower than usual and recent renal function and potassium have changed. You do not invent your own withholding threshold. You identify that the context has changed and escalate for a patient specific decision.

Example 3: insulin and a delayed meal

A patient has insulin prescribed but their meal has been delayed. Instead of guessing what to do with the dose, check the exact insulin, blood glucose, timing, prescription and local plan, then ask the registered nurse if anything is unclear. Different insulin preparations have different timing and action profiles.

Your role as a student nurse

Medicine rounds are an opportunity to develop pharmacology knowledge, but patient safety comes first. You should administer medicines only within your competence, university requirements, placement policy and appropriate supervision.

Useful student behaviours include:

• checking the prescription rather than relying on memory
• using the BNF or approved local medicine information when you are unsure
• asking why the patient is receiving the medicine
• connecting observations and blood results to medicine safety
• recognising when a patient has changed since the medicine was prescribed
• monitoring for therapeutic and adverse effects
• reporting suspected adverse reactions or medicine errors promptly
• asking the registered nurse or pharmacist when something does not fit

Knowing when to stop and check is part of medication competence. It is not a failure of knowledge.

The bit worth remembering

Learn the class to recognise the pattern. Check the individual medicine to keep the patient safe.

For every medicine, come back to three questions: Why is this patient receiving it? What must be checked before it is given? What should happen afterwards?

References and trusted UK sources

• Joint Formulary Committee (2026) British National Formulary. Available at: https://bnf.nice.org.uk/
• National Institute for Health and Care Excellence (NICE) (2015) Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NICE guideline NG5. Available at: https://www.nice.org.uk/guidance/ng5
• Scottish Government (2026) Polypharmacy Guidance: appropriate prescribing, making medicines safe, effective and sustainable 2026 to 2029. Available at: Scottish Government polypharmacy guidance
• Medicines and Healthcare products Regulatory Agency (MHRA) (2020) SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness. Available at: MHRA Drug Safety Update
• Medicines and Healthcare products Regulatory Agency (MHRA) (2015) High strength, fixed combination and biosimilar insulin products: minimising the risk of medication error. Available at: MHRA Drug Safety Update
• Nursing and Midwifery Council (NMC) (2018) The Code: Professional standards of practice and behaviour for nurses, midwives and nursing associates. Available at: https://www.nmc.org.uk/standards/code/
• Nursing and Midwifery Council (NMC) (2018) Standards of proficiency for registered nurses. Available at: NMC standards of proficiency

This article is for education and placement preparation. It does not replace a prescription, medicine specific information, clinical assessment, local policy or supervision.